Together, these in vivo and in vitro findings demonstrate that CKD-induced uremic toxins—particularly IS—are sufficient to drive USP38 upregulation in cardiomyocytes, and that systemic IS reduction can mitigate this effect. Here, USP38 is linked to chronic kidney disease.